| 000 | 00818 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250510211119.0 | ||
| 264 | 0 | _c19790124 | |
| 008 | 197901s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(78)91843-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolt, D W | |
| 245 | 0 | 0 |
_aDigoxin bioavailability. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 1978 |
||
| 300 |
_a1103 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aDigoxin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8099 _gp. 1103 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(78)91843-3 _zAvailable from publisher's website |
| 999 |
_c80179 _d80179 |
||